MCR American Pharmaceuticals recently began selling a new congestion relieving medication called Congestinex PE that relieves common cold symptoms.

Brooksville, Florida — April 23, 2012

MCR American Pharmaceuticals officially debuted its latest cold-fighting medication called Congestinex PE, an antitussive, expectorant and decongestant. The product was announced two weeks ago and is marketed to medical professionals and consumers on the company’s Web site.

Congestinex PE, which arrives in four-ounce bottles, relieves symptoms due to common cold, hay fever or other respiratory allergies. Congestinex PE arrives in grape flavor and is suitable for ages six and older.

MCR American Pharmaceuticals explains the benefits to such medication is the low dose of Dextromethorphan, Guaifenesin, and Phenylepherine. The low dosage of such ingredients ensures the medication is suitable for young ages and is safe to consume.

“The milligram strength in the product makes the medications suitable for a range of patients,” said Danny Ambrose, an executive at MCR American Pharmaceuticals. “MCR American Pharmaceuticals manufactured this product to help relieve the common cold symptoms that can really drain patients.”

MCR American Pharmaceuticals manufactures other cold-fighting medication groups called Maxiphen, Maxifed and Super-Tuss. Each medication group consists of products that are sold on the company’s Web site and aim to relieve patients from colds and flu-like symptoms.

“MCR American Pharmaceuticals offers a wide variety of products that work to relieve patients of the common cold, sinusitis, hay fever and allergic rhinitis,” Ambrose said.

More About MCR American Pharmaceuticals

MCR American Pharmaceuticals is a specialty pharmaceutical company focused on the marketing, development, sales and distribution of the highest quality pharmaceuticals. MCR American Pharmaceuticals was founded by Jack Reagin in 1991 in Birmingham, AL and quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by Dave Ambrose and was relocated to Brooksville, FL and in 2008, MCR American Pharmaceuticals was acquired by Neuro-HiTech. Today MCR American Pharmaceuticals’ products are marketed throughout the United States and sold directly to the general public as well as medical offices, wholesalers, distributors and local pharmacies.

For additional information, interview and image requests contact Virtuos Online.